p.118 抽出テキスト

928. Assis FR, Krishnan A, Zhou X, James CA, Murray B, Tichnell C, et al. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2019;16:1003–1010. https://doi.org/10.1016/j.hrthm. 2019.01.019 929. Shen L-S, Liu L-M, Zheng L-H, Hu F, Hu Z-C, Liu S-Y, et al. Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. J Geriatr Cardiol 2020;17:694–703. https://doi.org/10.11909/j.issn.1671- 5411.2020.11.001 930. Romero J, Patel K, Briceno D, Alviz I, Gabr M, Diaz JC, et al. Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2020;31:2022–2031. https://doi.org/10.1111/jce.14593 931. Christiansen MK, Haugaa KH, Svensson A, Gilljam T, Madsen T, Hansen J, et al. Incidence, predictors, and success of ventricular tachycardia catheter ablation in arrhythmogenic right ventricular cardiomyopathy (from the Nordic ARVC Registry). Am J Cardiol 2020;125:803–811. https://doi.org/10.1016/j.amjcard.2019.11.026 932. Briceno DF, Liang JJ, Shirai Y, Markman TM, Chahal A, Tschabrunn C, et al. Characterization of structural changes in arrhythmogenic right ventricular cardiomyopathy with recurrent ventricular tachycardia after ablation: insights from repeat electroanatomic voltage mapping. Circ Arrhythm Electrophysiol 2020;13:e007611. https:// doi.org/10.1161/CIRCEP.119.007611 933. Laredo M, Da Silva L, Extramiana F, Lellouche N, Varlet E, Amet D, et al. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2020;17:41–48. https://doi.org/10.1016/j.hrthm.2019.06.022 934. Berruezo A, Acosta J, Fernandez-Armenta J, Pedrote A, Barrera A, Arana-Rueda E, et al. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study. Europace 2017;19:607–616. https://doi.org/10.1093/europace/ euw212 935. Finocchiaro G, Papadakis M, Robertus JL, Dhutia H, Steriotis AK, Tome M, et al. Etiology of sudden death in sports: insights from a United Kingdom regional registry. J Am Coll Cardiol 2016;67:2108–2115. https://doi.org/10.1016/j.jacc.2016.02.062 936. de Noronha SV, Sharma S, Papadakis M, Desai S, Whyte G, Sheppard MN. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study. Heart 2009;95:1409–1414. https://doi.org/10.1136/hrt.2009.168369 937. D’Silva A, Papadakis M. Sudden cardiac death in athletes. Eur Cardiol 2015;10:48–53. https://doi.org/10.15420/ecr.2015.10.01.48 938. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003;42: 1959–63. https://doi.org/10.1016/j.jacc.2003.03.002 939. Bosman LP, Sammani A, James CA, Cadrin-Tourigny J, Calkins H, van Tintelen JP, et al. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. Heart Rhythm 2018;15:1097–1107. https://doi.org/ 10.1016/j.hrthm.2018.01.031 940. Orgeron GM, Te Riele A, Tichnell C, Wang W, Murray B, Bhonsale A, et al. Performance of the 2015 International Task Force Consensus Statement risk stratification algorithm for implantable cardioverter-defibrillator placement in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol 2018; 11:e005593. https://doi.org/10.1161/CIRCEP.117.005593 941. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018;72:e91–e220. https://doi.org/ 10.1016/j.jacc.2017.10.054 942. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006;113:776–782. https:// doi.org/10.1161/CIRCULATIONAHA.105.561571 943. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108: 3084–3091. https://doi.org/10.1161/01.CIR.0000103130.33451.D2 944. Link MS, Laidlaw D, Polonsky B, Zareba W, McNitt S, Gear K, et al. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. J Am Coll Cardiol 2014;64:119–125. https://doi.org/10.1016/j.jacc. 2014.04.035 945. Cadrin-Tourigny J, Bosman LP, Wang W, Tadros R, Bhonsale A, Bourfiss M, et al. Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration. Circ Arrhythm Electrophysiol 2021;14:e008509. https://doi. org/10.1161/CIRCEP.120.008509 946. Platonov PG, Haugaa KH, Bundgaard H, Svensson A, Gilljam T, Hansen J, et al. Primary prevention of sudden cardiac death with implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2019; 123:1156–1162. https://doi.org/10.1016/j.amjcard.2018.12.049 947. Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, et al. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol 2011;58:1485–1496. https://doi.org/10.1016/j.jacc.2011.06.043 948. Watkins DA, Hendricks N, Shaboodien G, Mbele M, Parker M, Vezi BZ, et al. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. Heart Rhythm 2009;6(11 Suppl):S10–S17. https://doi.org/10.1016/j.hrthm. 2009.08.018 949. Hulot J-S, Jouven X, Empana J-P, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2004;110:1879–1884. https://doi.org/10.1161/01.CIR.0000143375.93288.82 950. Mazzanti A, Ng K, Faragli A, Maragna R, Chiodaroli E, Orphanou N, et al. Arrhythmogenic right ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk. J Am Coll Cardiol 2016;68:2540–2550. https://doi.org/10.1016/j.jacc.2016. 09.951 951. Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, et al. Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document in collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging 2017;18:1090–1121. https://doi. org/10.1093/ehjci/jex034 952. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF III, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29: 277–314. https://doi.org/10.1016/j.echo.2016.01.011 953. Fenton MJ, Chubb H, McMahon AM, Rees P, Elliott MJ, Burch M. Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children. Heart 2006;92: 85–89. https://doi.org/10.1136/hrt.2004.049502 954. Saeed M, Liu H, Liang C-H, Wilson MW. Magnetic resonance imaging for characterizing myocardial diseases. Int J Cardiovasc Imaging 2017;33:1395–1414. https://doi.org/10. 1007/s10554-017-1127-x 955. Arbustini E, Morbini P, Grasso M, Fasani R, Verga L, Bellini O, et al. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. J Am Coll Cardiol 1998;31:645–653. https://doi.org/10.1016/S0735-1097(98)00026-6 956. Arbustini E, Grasso M, Rindi G, Arosio P, Gavazzi A, Diegoli M, et al. H and L ferritins in myocardium in iron overload. Am J Cardiol 1991;68:1233–1236. https://doi.org/10. 1016/0002-9149(91)90202-V 957. Koeppen AH, Ramirez RL, Becker AB, Bjork ST, Levi S, Santambrogio P, et al. The pathogenesis of cardiomyopathy in Friedreich ataxia. PLoS One 2015;10:e0116396. https://doi.org/10.1371/journal.pone.0116396 958. Dixit MP, Greifer I. Nephropathic cystinosis associated with cardiomyopathy: a 27-year clinical follow-up. BMC Nephrol 2002;3:8. https://doi.org/10.1186/1471- 2369-3-8 959. Giovannoni I, Callea F, Travaglini L, Amodeo A, Cogo P, Secinaro A, et al. Heart transplant and 2-year follow up in a child with generalized arterial calcification of infancy. Eur J Pediatr 2014;173:1735–1740. https://doi.org/10.1007/s00431-014-2447-7 960. Gambarin FI, Disabella E, Narula J, Diegoli M, Grasso M, Serio A, et al. When should cardiologists suspect Anderson–Fabry disease? Am J Cardiol 2010;106:1492–1499. https://doi.org/10.1016/j.amjcard.2010.07.016 961. Ben-Ami R, Puglisi J, Haider T, Mehta D. The Mount Sinai Hospital clinicalpathological conference: a 45-year-old man with Pompe’s disease and dilated cardiomyopathy. Mt Sinai J Med 2001;68:205–212. 962. Kawano H, Kawamura K, Kanda M, Ishijima M, Abe K, Hayashi T, et al. Histopathological changes of myocytes in restrictive cardiomyopathy. Med Mol Morphol 2021;54:289–295. https://doi.org/10.1007/s00795-021-00293-7 963. Kaski JP, Syrris P, Burch M, Tome-Esteban MT, Fenton M, Christiansen M, et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart 2008;94:1478–1484. https://doi.org/10.1136/hrt. 2007.134684 964. Mogensen J, van Tintelen JP, Fokstuen S, Elliott P, van Langen IM, Meder B, et al. The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics. Eur Heart J 2015;36:1367–1370. https:// doi.org/10.1093/eurheartj/ehv122 965. Menon SC, Michels VV, Pellikka PA, Ballew JD, Karst ML, Herron KJ, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet 2008;74:445–454. https://doi.org/10.1111/j.1399-0004.2008. 01062.x 966. Burke MA, Cook SA, Seidman JG, Seidman CE. Clinical and mechanistic insights into the genetics of cardiomyopathy. J Am Coll Cardiol 2016;68:2871–2886. https://doi. org/10.1016/j.jacc.2016.08.079 Downloaded from academic.oup.com/eurheartj/article/44/37/3503/7246608 by guest on 07 October 2026